Sorafenib (Nexavar) is a medication used to treat various types of cancer. It is a kinase inhibitor, meaning that it prevents the protein enzymes from allowing cancer cells to replicate, divide and enlarge. It is used to treat kidney cancer and liver cancer and has been shown to be effective in some cases.

Effects to be taken with care

Sorafenib is taken orally with a full glass of water on an empty stomach about one hour before meals or two hours after meals. The same dose needs to be taken at the same time each day and it is important to take the medication with food if it upsets your stomach. Common side effects of sorafenib include nausea, vomiting, diarrhoea and abdominal pain. These usually last a few days or less and can usually be managed with anti-nausea medications.

Results from the clinical trial

Sorafenib has been shown in several clinical trials to be effective in reducing tumour size and extending the lives of those with kidney and liver cancer. One study of participants who had untreated advanced kidney cancer showed that using sorafenib with interferon significantly improved their survival rate and quality of life. Additionally, a study of liver cancer patients who had previously had radiation or surgery found that those taking sorafenib had a significantly longer median overall survival.

Conclusion

In conclusion, sorafenib tablet 200mg is an effective medication for the treatment of kidney and liver cancer. It is usually taken orally and can cause side effects such as nausea, vomiting and diarrhoea. Studies have shown that sorafenib can prolong overall survival in those with advanced kidney and liver cancer, while also improving their quality of life. It is important to speak to a healthcare provider to discuss the potential risks and benefits of taking this medication.

FAQs

1. What are the side effects?

The most common side effects are nausea, vomiting, diarrhoea and abdominal pain 

1. how is it supposed to be taken?

Sorafenib is taken orally with a full glass of water on an empty stomach about one hour before meals or two hours after meals

1. What are the results of clinical trials?

Sorafenib has been shown in several clinical trials to be effective in reducing tumour size and extending the lives of those with kidney and liver cancer